Celldex scraps antibody in prurigo nodularis after Phase 2 flop

Anthony Marucci, Celldex CEO July 22, 2026 06:49 AM EDT R&D Celldex scraps an­ti­body in itchy skin nod­ules af­ter Phase 2 flop Reynald Castaneda Deputy Editor Celldex said on Tues­day it will stop in­ves­ti­gat­ing its mast cell-tar­get­ing mon­o­clon­al an­ti­body in a type of chron­ic itch dis­ease af­ter it failed on all … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER